Health

Moderna Vaccine Protects Monkeys from Coronavirus: Study

Moderna’s experimental coronavirus vaccine has built immunity in monkeys and protected them from being infected, according to results of a new trial study announced by the company Tuesday.

Monkeys receiving two doses of the vaccination achieved protection from infections in the lungs and nose, the company’s website said.

When given the mRNA-1273 vaccine, the monkeys showed a “robust immune response and protection” against COVID-19, Moderna said in the study’s conclusions, which were published in The New England Journal of Medicine.

Moderna President Stephen Hoge said he likes how the vaccine has performed so far.

“Given the similarity between the protective immune response generated by mRNA-1273 in this study and the immune response seen in humans in the recently published Phase One clinical data for the vaccine, we remain cautiously optimistic that mRNA-1273 will be able to prevent COVID-19 disease and may also slow the spread of SARS-CoV-2 by shortening the duration of the shedding,” Hoge said, Boston’s WBTS-TV reported.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker